Organon & Co.
OGN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821825
In the last 90 days, Organon & Co. insiders filed 0 open-market purchases and 1 sale; 636 institutions reported holding it in 13F filings for Q2 2026, worth $2.92B in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Organon & Co. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 726 | 12 | 741 | +27 |
| Shares | 199.3M | 229.1K | 205.7M | +6.66M (+3.3%) |
| Value | $3.81B | $4.38M | $3.07B | −$732.0M (−19.2%) |
12 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (129)
Institutions that held Organon & Co. at the end of Q4 2024 but not at the end of Q3 2024.
Showing the largest 100 of 129 by value.
Sold out (102)
Institutions that held Organon & Co. at the end of Q3 2024 and filed for Q4 2024 without it.
Showing the largest 100 of 102 by value.
Not filed for Q4 2024 yet (12)
Institutions that held Organon & Co. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Raymond James Financial Services Advisors, Inc. | 123,072 | $2.35M |
| Raymond James & Associates | 102,157 | $1.95M |
| Abich Financial Wealth Management LLC | 2,356 | $45.1K |
| M&R Capital Management Inc | 427 | $8.17K |
| ClariVest Asset Management LLC | 391 | $8.09K |
| Carmichael Hill & Associates, Inc. | 250 | $4.78K |
| Northwest Investment Counselors, LLC | 158 | $3.02K |
| FinTrust Capital Advisors, LLC | 115 | $2.20K |
| Naples Money Management LLC | 75 | $1.44K |
| Planning Capital Management Corp | 54 | $1.03K |
| Annapolis Financial Services, LLC | 50 | $957 |
| WFA of San Diego, LLC | 42 | $804 |